Neuroprotection by ketamine: a review of the experimental and clinical evidence.
Hudetz
Judith A
JA
Department of Anesthesiology, Medical College of Wisconsin and Clement J. Zablocki Veterans Administration Medical Center, 5000 W National Avenue, Milwaukee, WI 53295, USA. judith.hudetz@va.gov
Pagel
Paul S
PS
D002545:Brain Ischemia / Q000517:prevention & control*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D000860:Hypoxia / Q000209:etiology / Q000503:physiopathology; D007649:Ketamine / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D015427:Reperfusion Injury / Q000517:prevention & control*; D013514:Surgical Procedures, Operative
D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine